155 related articles for article (PubMed ID: 7577710)
1. Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors.
Iehlé C; Délos S; Guirou O; Tate R; Raynaud JP; Martin PM
J Steroid Biochem Mol Biol; 1995 Sep; 54(5-6):273-9. PubMed ID: 7577710
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells.
Délos S; Iehlé C; Martin PM; Raynaud JP
J Steroid Biochem Mol Biol; 1994 Mar; 48(4):347-52. PubMed ID: 8142312
[TBL] [Abstract][Full Text] [Related]
3. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
Délos S; Carsol JL; Ghazarossian E; Raynaud JP; Martin PM
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):375-83. PubMed ID: 8541234
[TBL] [Abstract][Full Text] [Related]
4. Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp.
Harris G; Azzolina B; Baginsky W; Cimis G; Rasmusson GH; Tolman RL; Raetz CR; Ellsworth K
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10787-91. PubMed ID: 1438277
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
[TBL] [Abstract][Full Text] [Related]
6. Stable expression of the human 5alpha-reductase isoenzymes type I and type II in HEK293 cells to identify dual and selective inhibitors.
Reichert W; Hartmann RW; Jose J
J Enzyme Inhib; 2001 Jan; 16(1):47-53. PubMed ID: 11496834
[TBL] [Abstract][Full Text] [Related]
7. Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase.
Frye SV; Bramson HN; Hermann DJ; Lee FW; Sinhababu AK; Tian G
Pharm Biotechnol; 1998; 11():393-422. PubMed ID: 9760689
[No Abstract] [Full Text] [Related]
8. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon.
Raynaud JP; Cousse H; Martin PM
J Steroid Biochem Mol Biol; 2002 Oct; 82(2-3):233-9. PubMed ID: 12477490
[TBL] [Abstract][Full Text] [Related]
10. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders.
Chen W; Zouboulis CC; Orfanos CE
Dermatology; 1996; 193(3):177-84. PubMed ID: 8944337
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.
Makridakis N; Reichardt JK
J Mol Endocrinol; 2005 Jun; 34(3):617-23. PubMed ID: 15956333
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
[TBL] [Abstract][Full Text] [Related]
13. Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat.
di Salle E; Giudici D; Biagini L; Cominato C; Briatico G; Panzeri A
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):381-5. PubMed ID: 7626485
[TBL] [Abstract][Full Text] [Related]
14. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
[TBL] [Abstract][Full Text] [Related]
15. Identification and partial characterization of two steroid 5 alpha-reductase isozymes in the canine prostate.
Span PN; Schalken JA; Sweep FG; Smals AG
Prostate; 1998 Feb; 34(3):222-30. PubMed ID: 9492851
[TBL] [Abstract][Full Text] [Related]
16. Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
Schwartz JI; Van Hecken A; De Schepper PJ; De Lepeleire I; Lasseter KC; Shamblen EC; Winchell GA; Constanzer ML; Chavez CM; Wang DZ; Ebel DL; Justice SJ; Gertz BJ
J Clin Endocrinol Metab; 1996 Aug; 81(8):2942-7. PubMed ID: 8768856
[TBL] [Abstract][Full Text] [Related]
17. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
[TBL] [Abstract][Full Text] [Related]
18. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
Liang T; Rasmusson GH; Brooks JR
J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871
[TBL] [Abstract][Full Text] [Related]
19. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
Di Salle E; Briatico G; Giudici D; Ornati G; Panzeri A
J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):241-8. PubMed ID: 8142301
[TBL] [Abstract][Full Text] [Related]
20. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
Hirsch KS; Jones CD; Audia JE; Andersson S; McQuaid L; Stamm NB; Neubauer BL; Pennington P; Toomey RE; Russell DW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5277-81. PubMed ID: 8389478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
